A detailed history of Monaco Asset Management Sam transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Monaco Asset Management Sam holds 150,561 shares of ORIC stock, worth $1.24 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
150,561
Previous 301,650 50.09%
Holding current value
$1.24 Million
Previous $2.13 Million 27.63%
% of portfolio
0.23%
Previous 0.35%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$7.52 - $11.9 $1.14 Million - $1.8 Million
-151,089 Reduced 50.09%
150,561 $1.54 Million
Q2 2024

Aug 07, 2024

BUY
$6.63 - $12.93 $1.14 Million - $2.22 Million
171,650 Added 132.04%
301,650 $2.13 Million
Q1 2024

May 09, 2024

SELL
$8.04 - $16.03 $1.21 Million - $2.4 Million
-150,000 Reduced 53.57%
130,000 $1.79 Million
Q4 2023

Feb 07, 2024

SELL
$5.41 - $9.43 $566,930 - $988,197
-104,793 Reduced 27.23%
280,000 $2.58 Million
Q3 2023

Nov 07, 2023

BUY
$6.05 - $9.28 $39,754 - $60,978
6,571 Added 1.74%
384,793 $2.33 Million
Q2 2023

Aug 08, 2023

SELL
$4.95 - $8.4 $858,958 - $1.46 Million
-173,527 Reduced 31.45%
378,222 $2.94 Million
Q1 2023

May 11, 2023

SELL
$4.26 - $6.75 $24,201 - $38,346
-5,681 Reduced 1.02%
551,749 $3.14 Million
Q4 2022

Jan 31, 2023

BUY
$2.41 - $5.89 $521,157 - $1.27 Million
216,248 Added 63.38%
557,430 $3.28 Million
Q3 2022

Oct 31, 2022

SELL
$3.15 - $5.24 $74,210 - $123,449
-23,559 Reduced 6.46%
341,182 $1.09 Million
Q2 2022

Aug 01, 2022

BUY
$2.7 - $7.07 $984,800 - $2.58 Million
364,741 New
364,741 $1.63 Million

Others Institutions Holding ORIC

About Oric Pharmaceuticals, Inc.


  • Ticker ORIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,576,700
  • Market Cap $325M
  • Description
  • ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...
More about ORIC
Track This Portfolio

Track Monaco Asset Management Sam Portfolio

Follow Monaco Asset Management Sam and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monaco Asset Management Sam, based on Form 13F filings with the SEC.

News

Stay updated on Monaco Asset Management Sam with notifications on news.